← Home
© 2024 - 2025 InsightfulValue.com. All rights reserved.
📢 Press Releases
Date | Press release |
---|---|
2025-05-29 20:15:00 | Astellas Enters Exclusive License Agreement With Evopoint Biosciences For Xnw27011, A Novel Clinical-stage Antibody-drug Conjugate Targeting Cldn18.2 - agreement grants astellas exclusive worldwide rights (excluding china’s mainland, hong kong, macao and taiwan region) to develop and commercialize xnw27011 - - xnw27011 has demonstrated encouraging monotherapy efficacy in an ongoing phase 1/2 study of patients with solid tumors, including gastric cancer, gastroesophageal cancer and pancreatic cancer - - evopoint to receive a $130 million upfront payment and is eligible to receive up to $70 million near-term payments, and additional milestone payments associated with development, regulatory and commercialization milestones totaling up to $1. 34 billion, as well as royalties on net sales of xnw27011, if approved - tokyo and suzhou, china , may 29, 2025 /prnewswire/ -- astellas pharma inc. (tse: 4503, president and ceo: naoki okamura, ’astellas’) and evopoint biosciences (evopoint biosciences co., ltd. |
2025-05-28 10:00:00 | Astellas Announces Second Annual Patient Advocacy Organization (pao) Action Week™ To Empower Patients And Caregivers Building on a successful inaugural year, the initiative sponsored by astellas’ patient centricity team continues to connect individuals with vital resources and support from patient advocacy organizations northbrook, ill. , may 28, 2025 /prnewswire/ -- astellas patient centricity is pleased to announce the second annual patient advocacy organization (pao) action week ™ taking place june 9-13, 2025. |
2025-05-21 11:00:00 | Astellas And Mbc Biolabs Announce The 2025 Astellas Future Innovator Prize Awarded To Deepseq.ai & Serna Bio Both companies have earned a year-long opportunity for access to a distinguished life-science incubator in san francisco along with the invaluable expertise provided by astellas to advance their research endeavors award helps biotech startups accelerate early research efforts northbrook, ill. , may 21, 2025 /prnewswire/ -- astellas pharma u.s. inc. (head of commercial: mike petroutsas, ’astellas’), and mbc biolabs, a premier launchpad for early-stage life-science companies, today announced deepseq.ai, inc. & serna bio as the winners of the astellas sponsored future innovator prize at mbc biolabs. |
2025-05-01 09:00:00 | Astellas To Present New Data In Geographic Atrophy At Upcoming Ophthalmology Annual Congresses Arvo and rwc abstracts feature analyses on biomarkers, mechanism of disease, patient experience and other data from izervay ™ (avacincaptad pegol intravitreal solution) pivotal studies tokyo , may 1, 2025 /prnewswire/ -- astellas pharma inc. (tse: 4503, president and ceo: naoki okamura, ’astellas’), maker of izervay™ (avacincaptad pegol intravitreal solution), a c5 inhibitor for the treatment of geographic atrophy (ga)*, will highlight new data that enhances continued understanding of the science of ga, and the experience of patients living with the progressive disease at the association for research in vision and ophthalmology annual meeting (arvo), may 4-8, salt lake city, utah, and retina world congress (rwc), may 8-11, fort lauderdale, florida. the data comprises nine abstracts, including two oral presentations, featuring analyses on biomarkers, patient experience, mechanism of disease and other insights from the gather phase 3 studies of izervay for the treatment of ga secondary to age-related macular degeneration (amd). |
2025-03-24 11:48:00 | Singlera Genomics Presented Non-invasive Testicular Toxicity Detection With Astellas At 2025 Sot Meeting San diego, march 24, 2025 (globe newswire) -- singlera genomics presented results showing a refined approach to detect drug-induced testicular toxicity using singlera’s cell-free dna methylation technology with astellas during the sot 2025 annual meeting. |
2025-02-27 10:00:00 |
|
2025-02-12 18:32:00 |
|
2025-02-05 03:59:00 |
|
2025-02-04 01:30:00 |
|
2024-12-25 20:30:00 |
|
2024-12-05 08:49:00 |
|
2024-11-20 13:00:00 |
|
2024-10-10 03:00:00 |
|
2024-10-08 09:27:00 |
|
2024-10-01 16:24:00 |
|

📰 Browse additional press releases for Astellas Pharma!
Sign up for free or log in💡 Learn smarter stock picks with "The Checklist Value Investor — A Smarter Way to Pick Stocks"